News

The Medicare program is expected to see some aggregate savings from the negotiated drug prices. Beneficiaries, because of out-of-pocket caps next year, may not see the benefit, that is until the next round or two of negotiations if CMS choses drugs that are not heavily rebated.

Associate director of healthcare and public health programs at the Digital Medicine Society (DiMe), a global nonprofit and professional home for digital medicine

This therapy is a first-in-class treatment for chronic graft-versus-host disease, which develops in roughly 42% of those who receive a stem cell of bone marrow transplant.

The negotiated prices range from 38% to 79% discounts off of list prices, according to the Department of Health and Human Services.

Vice president of legal and compliance at Abarca Health, a pharmacy benefits manager and healthcare technology company.

The system, called ThecaFlex DRx, allows subcutaneous administration of Spinraza (nusinersen) directly into the cerebrospinal fluid, and aims to replace the current administrative route through lumbar punctures.

In 2016, Medicare expenses for traumatic brain injuries totaled more than $16 billion and car crashes were the third-leading cause of hospitalizations, emergency room visits and deaths.

The KFF analysis reported on the number of prior authorizations by plans, but found the data do not contain enough information to assess prior authorization by type of service, type of plan or reasons for denials.

Chief medical officer, complex care, AbsoluteCare, an integrated healthcare provider headquartered in Columbia, Maryland

Health Equity Officer at UCare, an independent, nonprofit health plan company with members in Minnesota and western Wisconsin

Healthcare organizations need prompt, actionable advice to enhance their cyber resilience, ensuring more secure and convenient communications and services for patients, shareholders, third parties, staff, and other affiliates moving forward.

Director, specialty clinical solutions, Prime Therapeutics LLC, a pharmacy benefits manager in Eagan, Minnesota

Director, specialty pharmacy, Horizon Blue Cross Blue Shield of New Jersey

Enzeevu is biosimilar to Eylea (aflibercept), which was FDA-approved in 2019.

Vice president of implementation and sales, Longevity Health, a clinical services company and institutional special needs plan (ISNP) for nursing home residents

Here’s what you missed this week on Managed Healthcare Executive.

Executive director, specialty digital and patient innovation, CVS Health

Neffy is the first epinephrine product that does not need to be administered by injection and the first new epinephrine delivery method in 35 years. It will be available at a starting price of $25.

Population health analyst on a dedicated health equity team, Optum Rx

Co-founder and CEO at Fabric Health, a public benefit corporation that conducts outreach about health benefits at laundromats

Breast cancer treatment delays can lead to a higher mortality rate and more expenses.

Director, formulary operations, Capital Rx, a pharmacy benefits manager and healthcare technology company

Total revenue for the company increased for the second quarter of 2024, but CVS Health is facing increased medical cost trend in its Medicare/Medicaid health plans and lowered revenue in its pharmacy benefit business. As a result, CVS Health has lowed its outlook for the year and parted ways with its Aetna president.

After less than a year, Aetna president Brian Kane is out at CVS Health, it was announced today at an investor call. The change was made to address the continued pressure in the company’s healthcare benefits business.

Experts predict that from 2024 to 2032, the breast cancer market will grow at a CAGR of 7.09%.

Intranasal administration is a novel delivery method for the treatment of inflammatory human diseases.

The CDC has raised the recommded age at which people should get vaccinated to 75 and there are now three FDA-approved RSV vaccines